Eureka Therapeutics competitors

Zippia score 3.8

Competitor Summary. See how Eureka Therapeutics compares to its main competitors:

AbVitro has the most employees (350).
The oldest company is GT Biopharma, founded in 1965.

Work at Eureka Therapeutics?

Share your experience

Eureka Therapeutics vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Eureka Therapeutics	2006	3.8	Emeryville, CA	1	$500,000	50
Immunome	2008	4.0	Exton, PA	1	$9.0M	29
Theraclone Sciences	2004	3.9	Seattle, WA	1	$470,000	2
MabVax Therapeutics	2006	3.3	San Diego, CA	1	$1.6M	11
Genocea	2006	3.7	Cambridge, MA	1	-	59
GT Biopharma	1965	3.2	Westlake Village, CA	1	$27,000	2
AbVitro	2012	3.9	Boston, MA	1	$10.0M	350
Siamab Therapeutics	2006	3.6	Newton, MA	1	$700,000	12
GO Therapeutics	2014	3.6	Cambridge, MA	1	$370,000	11

Rate how well Eureka Therapeutics differentiates itself from its competitors.

Eureka Therapeutics salaries vs competitors

Compare Eureka Therapeutics salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Eureka Therapeutics	$50,236	$24.15	-

Compare Eureka Therapeutics job title salaries vs competitors

Company	Highest salary	Hourly salary
Eureka Therapeutics	$34,743	$16.70
Genocea	$37,610	$18.08
MabVax Therapeutics	$33,751	$16.23
Siamab Therapeutics	$32,576	$15.66
Immunome	$32,390	$15.57
GT Biopharma	$32,270	$15.51
Theraclone Sciences	$32,232	$15.50
AbVitro	$32,041	$15.40
GO Therapeutics	$32,034	$15.40

Do you work at Eureka Therapeutics?

Is Eureka Therapeutics able to compete effectively with similar companies?

Eureka Therapeutics jobs

Eureka Therapeutics and similar companies CEOs

CEOBio

Chip Clark

Genocea

Prior to joining Genocea,Chip co-founded and served as Chief Business Officer of Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA). Before that, Chip was a Principal at Care Capital, LLC, a venture capital firm investing in biopharmaceutical companies, after serving in a variety of commercial roles at SmithKline Beecham (now GlaxoSmithKline). Chip holds a B.A. from Harvard University and an M.B.A. from The Wharton School at the University of Pennsylvania.

John David Hansen

MabVax Therapeutics

J. David Hansen is a President & Chief Executive Officer at MABVAX THERAPEUTICS HOLDINGS, INC. and Board Member at MABVAX THERAPEUTICS HOLDINGS, INC..

Thayer White

GO Therapeutics

Thayer White is a CEO & CSO at GO Therapeutics. He has worked as Dir Biochen at CTI BIOPHARMA CORP. Thayer studied at University of Washington between 1977 and 1993.

Norrie J. W. Russell

Siamab Therapeutics

Norrie J. W. Russell is a CEO at Siamab Therapeutics, Inc..

Michael Breen

GT Biopharma